OneSource Spec Standalone September 2025 Net Sales at Rs 375.19 crore, up 52.89% Y-o-Y

Quarterly Net Profit at Rs. 37.10 crore in September 2025 up 164.09% from Rs. 57.89 crore in September 2024. EBITDA stands at ...

Buy Onesource Specialty Pharma; target of Rs 2475 : ICICI Securities

ICICI Securities is bullish on Onesource Specialty Pharma has recommended buy rating on the stock with a target price of Rs ...
TipRanks on MSN

OneSource Specialty Pharma Releases Q2FY26 Earnings Presentation

An update from OneSource Specialty Pharma Limited ( ($IN:ONESOURCE) ) is now available. OneSource Specialty Pharma Limited has released its ...

Weight-loss drug boom helps OneSource lift revenue target to $500 mn

OneSource Specialty Pharma has raised its FY28 revenue forecast from $400 million to over $500 million, driven by strong ...

OneSource optimistic on weight-loss drug prospects, raises FY28 revenue guidance to over $500 mn

OneSource Specialty Pharma has raised its FY28 revenue forecast from $400 million to over $500 million, driven by strong demand in its drug-device and biologics sectors.

OneSource Specialty Pharma reports consolidated net profit of Rs 10.49 crore in the September 2025 quarter

Sales rise 12.49% to Rs 375.76 crore. Net profit of OneSource Specialty Pharma reported to Rs 10.49 crore in the quarter ended September 2025 as against net loss of Rs 42.08 crore ...

OneSource Specialty Pharma Ltd

Stay updated with the latest stock market news and live updates. Get real-time insights on Sensex Today, Nifty Live, stock market today, IPO news and more on Business Standard.
Benzinga.com

Breaking Down Custom Truck One Source: 4 Analysts Share Their Views

Ratings for Custom Truck One Source (NYSE:CTOS) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table summarizes their recent ...